Title: Providing for consideration of the bill (H.R. 4566) to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act; providing for consideration of the bill (H.R. 5247) to authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with another eligible illness, and for other purposes; and for other purposes.
Policy area: Congress

Summary:
Sets forth the rule for consideration of the bill (H.R. 4566) to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act; providing for consideration of the bill (H.R. 5247) to authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with another eligible illness, and for other purposes.

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 787 Reported in House (RH)]

<DOC>





                                                 House Calendar No. 133
115th CONGRESS
  2d Session
H. RES. 787

                          [Report No. 115-613]

 Providing for consideration of the bill (H.R. 4566) to amend the Dodd-
Frank Wall Street Reform and Consumer Protection Act to provide relief 
   to nonbanks from certain stress test requirements under such Act; 
 providing for consideration of the bill (H.R. 5247) to authorize the 
  use of eligible investigational drugs by eligible patients who have 
been diagnosed with a stage of a disease or condition in which there is 
reasonable likelihood that death will occur within a matter of months, 
or with another eligible illness, and for other purposes; and for other 
                               purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             March 19, 2018

   Mr. Burgess, from the Committee on Rules, reported the following 
resolution; which was referred to the House Calendar and ordered to be 
                                printed

_______________________________________________________________________

                               RESOLUTION


 
 Providing for consideration of the bill (H.R. 4566) to amend the Dodd-
Frank Wall Street Reform and Consumer Protection Act to provide relief 
   to nonbanks from certain stress test requirements under such Act; 
 providing for consideration of the bill (H.R. 5247) to authorize the 
  use of eligible investigational drugs by eligible patients who have 
been diagnosed with a stage of a disease or condition in which there is 
reasonable likelihood that death will occur within a matter of months, 
or with another eligible illness, and for other purposes; and for other 
                               purposes.

    Resolved, That upon adoption of this resolution it shall be in 
order to consider in the House the bill (H.R. 4566) to amend the Dodd-
Frank Wall Street Reform and Consumer Protection Act to provide relief 
to nonbanks from certain stress test requirements under such Act. All 
points of order against consideration of the bill are waived. In lieu 
of the amendment in the nature of a substitute recommended by the 
Committee on Financial Services now printed in the bill, an amendment 
in the nature of a substitute consisting of the text of Rules Committee 
Print 115-65 shall be considered as adopted. The bill, as amended, 
shall be considered as read. All points of order against provisions in 
the bill, as amended, are waived. The previous question shall be 
considered as ordered on the bill, as amended, and on any further 
amendment thereto, to final passage without intervening motion except: 
(1) one hour of debate equally divided and controlled by the chair and 
ranking minority member of the Committee on Financial Services; (2) the 
further amendment printed in the report of the Committee on Rules 
accompanying this resolution, if offered by the Member designated in 
the report, which shall be in order without intervention of any point 
of order, shall be considered as read, shall be separately debatable 
for the time specified in the report equally divided and controlled by 
the proponent and an opponent, and shall not be subject to a demand for 
a division of the question; and (3) one motion to recommit with or 
without instructions.
    Sec. 2.  Upon adoption of this resolution it shall be in order to 
consider in the House the bill (H.R. 5247) to authorize the use of 
eligible investigational drugs by eligible patients who have been 
diagnosed with a stage of a disease or condition in which there is 
reasonable likelihood that death will occur within a matter of months, 
or with another eligible illness, and for other purposes. All points of 
order against consideration of the bill are waived. The bill shall be 
considered as read. All points of order against provisions in the bill 
are waived. The previous question shall be considered as ordered on the 
bill and on any amendment thereto to final passage without intervening 
motion except: (1) one hour of debate equally divided and controlled by 
the chair and ranking minority member of the Committee on Energy and 
Commerce; and (2) one motion to recommit.
    Sec. 3.  The requirement of clause 6(a) of rule XIII for a two-
thirds vote to consider a report from the Committee on Rules on the 
same day it is presented to the House is waived with respect to any 
resolution reported through the legislative day of March 23, 2018.
    Sec. 4.  It shall be in order at any time on the legislative day of 
March 22, 2018, or March 23, 2018, for the Speaker to entertain motions 
that the House suspend the rules as though under clause 1 of rule XV. 
The Speaker or his designee shall consult with the Minority Leader or 
her designee on the designation of any matter for consideration 
pursuant to this section.
    Sec. 5.  Section 3(a) of House Resolution 5 is amended by striking 
"the first session of".
                                                 House Calendar No. 133

115th CONGRESS

  2d Session

                              H. RES. 787

                          [Report No. 115-613]

_______________________________________________________________________

                               RESOLUTION

 Providing for consideration of the bill (H.R. 4566) to amend the Dodd-
Frank Wall Street Reform and Consumer Protection Act to provide relief 
   to nonbanks from certain stress test requirements under such Act; 
 providing for consideration of the bill (H.R. 5247) to authorize the 
  use of eligible investigational drugs by eligible patients who have 
been diagnosed with a stage of a disease or condition in which there is 
reasonable likelihood that death will occur within a matter of months, 
or with another eligible illness, and for other purposes; and for other 
                               purposes.

_______________________________________________________________________

                             March 19, 2018

        Referred to the House Calendar and ordered to be printed